PMC:7029759 / 20660-20869 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"469","span":{"begin":125,"end":129},"obj":"Gene"},{"id":"478","span":{"begin":70,"end":74},"obj":"Disease"}],"attributes":[{"id":"A469","pred":"tao:has_database_id","subj":"469","obj":"Gene:59272"},{"id":"A478","pred":"tao:has_database_id","subj":"478","obj":"MESH:D045169"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"V infection ( Figure 1). This strategy was shown to effectively block SARS entry and replication in experiments 42. While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies d"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T354","span":{"begin":70,"end":74},"obj":"SP_10"},{"id":"T353","span":{"begin":85,"end":96},"obj":"GO:0006260"},{"id":"T352","span":{"begin":125,"end":129},"obj":"G_3;PG_10;PR:000003622"},{"id":"T351","span":{"begin":130,"end":138},"obj":"GO:0042571"},{"id":"T350","span":{"begin":197,"end":207},"obj":"GO:0042571"}],"text":"V infection ( Figure 1). This strategy was shown to effectively block SARS entry and replication in experiments 42. While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies d"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T119","span":{"begin":130,"end":138},"obj":"Body_part"}],"attributes":[{"id":"A119","pred":"fma_id","subj":"T119","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"V infection ( Figure 1). This strategy was shown to effectively block SARS entry and replication in experiments 42. While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies d"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T61","span":{"begin":2,"end":11},"obj":"Disease"},{"id":"T62","span":{"begin":70,"end":74},"obj":"Disease"}],"attributes":[{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"V infection ( Figure 1). This strategy was shown to effectively block SARS entry and replication in experiments 42. While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies d"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T132","span":{"begin":25,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"V infection ( Figure 1). This strategy was shown to effectively block SARS entry and replication in experiments 42. While no ACE2 antibody sequences are published in literature indexes, monoclonal antibodies d"}